We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

26 hedge funds and large institutions have $8.73M invested in Annovis Bio in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

8% more funds holding

Funds holding: 24 → 26 (+2)

1.46% less ownership

Funds ownership: 10.9% → 9.44% (-1.5%)

26% less capital invested

Capital invested by funds: $11.9M → $8.73M (-$3.14M)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Lynwood Capital Management
Ontario, Canada
+$137K
2
Koshinski Asset Management
Koshinski Asset Management
Illinois
+$109K
3
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
+$87.5K
4
FIA
FNY Investment Advisers
New York
+$33.3K
5
Bank of America
Bank of America
North Carolina
+$16.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$837K
2
Morgan Stanley
Morgan Stanley
New York
-$589K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$310K
4
Renaissance Technologies
Renaissance Technologies
New York
-$71K
5
EL
Essex LLC
Illinois
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.75M – – –
BlackRock
2
BlackRock
New York
$1.66M -$9.63K -881 -0.6%
Morgan Stanley
3
Morgan Stanley
New York
$636K -$589K -53,920 -49%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$479K +$2.94K +269 +0.6%
WFAG
5
Wescott Financial Advisory Group
Pennsylvania
$472K – – –
MWM
6
Modera Wealth Management
New Jersey
$351K -$4.37K -400 -1%
SIAP
7
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$306K +$87.5K +8,000 +42%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$289K -$361 -33 -0.1%
BCM
9
Bridgeway Capital Management
Texas
$268K – – –
Two Sigma Advisers
10
Two Sigma Advisers
New York
$204K -$310K -28,400 -61%
State Street
11
State Street
Massachusetts
$194K – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$189K -$71K -6,497 -28%
KCM
13
Knoll Capital Management
Florida
$161K – – –
LCM
14
Lynwood Capital Management
Ontario, Canada
$142K +$137K +12,500 New
EL
15
Essex LLC
Illinois
$118K -$13K -1,185 -10%
CC
16
Cannell & Co
New York
$113K – – –
Koshinski Asset Management
17
Koshinski Asset Management
Illinois
$113K +$109K +10,000 New
Wells Fargo
18
Wells Fargo
California
$99K +$44 +4 +0%
Bank of America
19
Bank of America
North Carolina
$99K +$16.3K +1,494 +21%
FIA
20
FNY Investment Advisers
New York
$41K +$33.3K +3,050 +508%
Osaic Holdings
21
Osaic Holdings
Arizona
$25K -$8.75K -800 -28%
Rockefeller Capital Management
22
Rockefeller Capital Management
New York
$11K – – –
IA
23
IFP Advisors
Florida
$6K – – –
UBS Group
24
UBS Group
Switzerland
$5K +$4.53K +414 New
Millennium Management
25
Millennium Management
New York
– -$837K -62,676 Closed
1
2

ANVS Hedge Fund Activity: Q2 2022 in Review

26 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2022, worth a combined $8.73M — down 26% from $11.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ANVS positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Lynwood Capital Management, opening a new position worth an estimated $137K. The largest seller was Millennium Management, exiting entirely with an estimated $837K sold.

  • 26 institutional investors held Annovis Bio (ANVS) as of Q2 2022, up from 24 in Q1 2022.
  • Funds reported $8.73M of Annovis Bio stock for Q2 2022, down 26% quarter-over-quarter.
  • 3 funds opened new Annovis Bio positions in Q2 2022 and 1 closed out, a net change of +2 holders.
  • The largest Annovis Bio buyer in Q2 2022 was Lynwood Capital Management, an estimated $137K added.
  • The largest Annovis Bio seller in Q2 2022 was Millennium Management, an estimated $837K sold.

Based on aggregated 13F filings for Q2 2022.